Validation of the Role of Levetiracetam for Newly Diagnosed GBM Patients
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
Prospective, open-labeled, multicenter cohort trial for validation of the role of
levetiracetam as a sensitizer of temozolomide in the treatment of newly diagnosed
glioblastoma patients.